‘CMC can find qualified hospitals for clinical trials’

Mr Jiang Peng is the director of China Medical City (CMC) Business Development International Center


Mr Jiang Peng, director, CMC Business Development International Center

CMC is considered to be one of the world's advanced biomedical R&D center. In his exclusive interview with BioSpectrum's Raj Gunashekar, he shares some of the detailed information on companies and the research facilities offered at CMC, along with conducting clinical trials, and also about the future outlook of the biomedical R&D center.

Q: Can you comment on the companies at CMC and its facilities?
Mr Jiang Peng: As the only national level medical and hi-tech zone with the largest scale and the most complete industrial chain in China.

CMC is dedicated to pharmaceutical and biomedical field, which includes R&D, manufacturing, distribution, and healthcare treatment.

The major well-known multinational firms in our park are AstraZeneca, Takeda, Boehringer Ingelheim, Chugai Pharmaceutical, Sanofi Pasteur, and Nestle Health Science.

Besides, we've had business negotiations with other MNCs as well.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email